Emerging at the UK, retatrutide, a innovative molecule, is sparking considerable excitement within the healthcare community regarding its promise for weight management . This dual GIP and GLP-1 target agonist appears to deliver a substantial advantage over current therapies, showing promising results in early clinical trials . Researchers … Read More